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DIETARY SODIUM AND BLOOD PRESSURE CHANGES 
IN HEMODIALYSIS PATIENTS UNDERGOING A 
LIBERALIZED RENAL DIET INTERVENTION 
 
Lauren Eve Chan 
51 Pages 
Objective: Investigate the impacts of individual liberalized renal diet counseling in conjunction 
with a volume reduction hemodialysis (HD) protocol. 
Design & Methods: Twenty-three maintenance HD patients (age = 55.7 ± 13.3y, 47.8% female), 
consented and completed this pilot intervention. Across the six-month intervention, participants 
received thrice weekly dietary counseling about a liberalized renal diet. Liberalized renal dietary 
guidelines promoted a low sodium diet with greater unprocessed food consumption, decreasing 
foods eaten outside the home, and increased food label reading. Participant HD sessions were 
conducted per a volume reduction protocol, gradually decreasing patient post-dialysis weight by 
removing an additional 200-300 mL/session. Preliminary outcome measures included dietary 
intake and knowledge, blood pressure (BP), anti-hypertensive medication use, and volume 
overload (VO).   
Results: From baseline (BL) to six months (6m), total sodium intake numerically decreased (BL 
2886 ± 1570.6 vs 6m 2315 ± 1095 mg, p=0.13), systolic BP (BL 160 ± 25 vs. 6m 156 ± 23 
mmHg, p=0.56) and diastolic BP (BL 81 ± 20 vs 6m 79 ± 15 mmHg, p= 0.73) showed no 
significant changes, but total number of anti-hypertensive medications prescribed to patients (BL 
3 ± 1 vs 6m 2 ± 1 medications) were significantly reduced (p=0.003). Additionally, significant 
improvements were noted in VO (BL 3.6L ± 3.9L vs 6m 2.5L ± 3.5L, p=0.01).  
 Conclusion: Liberalized renal diet education had little effect on sodium intake, likely 
contributing only minimally to BP control. Volume reduction protocol with gradual reduction of 
post dialysis weight resulted in significantly decreased VO, and maintenance of BP with 
coinciding decreases in anti-hypertensive medication usage. Our findings document intervention 
opportunities to improve BP and decrease medication usage for HD patients. 
 
 
KEYWORDS: hemodialysis, liberalized renal diet, volume reduction, blood pressure, sodium 
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CHAPTER I: MANUSCRIPT 
INTRODUCTION 
  Prevalence of end stage renal disease (ESRD) is increasing in the United States (US), 
with approximately 110,000 new cases each year.1 Patients with ESRD typically have less than 
15% function of their kidneys, a glomerular filtration rate (GFR) of <15.2 ESRD patients require 
either peritoneal dialysis or hemodialysis (HD) or other blood filtration treatments to supplement 
fluid and metabolic waste removal, with HD being the most common selection.2  
HD treatments are particularly important to remove minerals such as sodium, potassium, 
and phosphorus from the blood. These dietary minerals greatly impact fluid balance and can alter 
blood pressure (BP) levels if their concentrations are irregular.5 Increased levels of these 
minerals, sodium in particular, alter BP when concentrations are greater than normal causing 
increased fluid retention.6 Sodium consumption is also directly tied to thirst, and with additional 
sodium intake a patient will experience a strong physiological thirst sensation leading them to 
drink more fluid.6 By introducing more fluid to the system, the patient will increase their body 
fluid volume.6 Expanded body fluid, and in turn blood volume, can increase BP, leading many 
patients to develop or exacerbate pre-existing hypertension (HTN) or other cardiovascular (CV) 
risks such as aortic stiffness.7  
Currently, upwards of 80-90% of HD patients experience HTN.8 In an investigation with 
greater than 30,000 individual HD patients, large gains of body fluid between dialysis sessions, 
defined as > 4.0 kg, were correlated with higher risk of death over the following two years.9 With 
cardiovascular disease (CVD) being the main cause of death among ESRD patients, 
encompassing 41% of patient deaths,10 BP management strategies are critical for this population. 
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In the US, treatment for HD patients include both lifestyle and pharmaceutical approaches in 
addition to regular dialysis treatments to maintain healthy BP.3,4  
For improved BP and health management, HD patients are often counseled to follow the 
traditional renal diet to decrease their dietary mineral intake in an effort to manage their 
interdialytic blood mineral concentrations. Restricted foods include dairy, nuts, whole grains, 
fruits, and vegetables, making it a complicated and challenging diet to follow.11 With 
recommendations to limit traditionally heart healthy foods, HD patients may be at risk of 
consuming a pro-atherogenic diet that is low in fiber and micronutrients.11,12 In addition, HD 
patients often experience multiple barriers for dietary change that can vary from struggles 
learning to utilize new food items13, to the desire for more individualized dietary guidance.14  
Furthermore, most hypertensive American HD patients are prescribed anti-hypertensive 
medications as the primary treatment to decrease BP.15 Although anti-hypertensive BP 
medications are commonly used, their effectiveness in this population is questionable. For 
significant BP reduction, some HD patients need upwards of four medications to alter their 
BP.15,16,17 Additionally, medications are expensive to purchase, challenging to monitor and 
maintain, and can have other unwanted side effects including an increased risk for interdialytic 
hypotension.5,15,18 In efforts to significantly reduce and maintain appropriate BP levels, patients 
may need alternative treatments to medications.  
Controlling dietary sodium intake is an important component to managing BP. Currently 
recognized as part of the traditional renal diet, limiting sodium intake to less than 2,000 
milligrams per day can reduce fluid retention and BP in HD patients.6,19 Although sodium 
recommendations are typically given to HD patients, poor dietary sodium adherence is common. 
Poor adherence may be related to various barriers for dietary changes, including how confusing 
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and overwhelming the traditional renal diet is.11,13,14 Recent efforts to simplify the renal diet are 
being considered to help HD patients focus on sodium reduction to decrease the onset or 
progression of HTN. Additionally, a more liberalized diet may allow for patients to have greater 
food selection, more micronutrients, and increased fiber in their diet, a concern for many HD 
patients.11,20  
In addition to dietary adaptations, HTN and volume overload (VO) may be altered 
through volume reduction protocol with the removal of an additional 200-300 mL of fluid per 
HD session. A patient’s dry weight is often an estimation made by a nephrologist, rather than an 
objective measurement of the patient’s edema free body weight, and thus only dialyzing to the 
dry weight may leave excess fluid on the body and maintain an elevated BP.9,21 By seeking to 
remove a small amount of additional fluid during each dialysis session, the patient may come 
closer to their actual edema free body weight and gradually reduce their BP.21  
By reducing post dialysis weight each session and using dietary interventions such as the 
liberalized renal diet, patients may see a reduction in BP alongside a decreased need for BP 
medications. In turn, this may result in better CVD outcomes and lower mortality risk for HD 
patients.  
Following a six-month intervention with education on a liberalized renal diet and the use 
of volume reduction protocol, we hypothesized patients in this pilot study would experience a 
decline in total daily sodium intake (mg), decrease in systolic and diastolic BP (mmHg), and a 
reduction in the number of anti-hypertensive medications used.  
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METHODOLOGY 
Design and Subjects  
This study served the purpose of documenting how low sodium focused, liberalized renal 
nutrition recommendations can affect dietary sodium intake, BP, anti-hypertensive medication, 
and prevalence of VO in U.S. HD patients. This is a retrospective analysis of a prospective, 
multi-center, intervention conducted in Central Illinois.  
Purposive, convenience sampling was used to identify 32 HD patients from participating 
HD clinics in Peoria and Champaign, Illinois. Inclusion criteria was HD treatment for ESRD, 
and the exclusion criteria was decompensated heart failure as classified by a physician. Patients 
gave written consent for participation and signed health information release forms prior to 
starting, allowing for research staff to access medical information including height, weight, 
medications, HD and comorbidity history, and other laboratory reports. Following consent, all 
patients were evaluated by a registered dietitian and a nephrologist for safety clearance to 
participate. The University of Illinois and Illinois State University Institutional Review Boards 
approved this protocol. All procedures were in accordance of the Declaration of Helsinki. 
Data Collection Periods 
The two data collection periods included the week prior to a patient starting the 
intervention, and the week following the conclusion of the six-month intervention treatment. 
During each week-long collection period, patients underwent a series of measures at their regular 
HD sessions including dietary intake, nutrition knowledge, BP, medication use, VO, and other 
related values. Collection was conducted by a trained member of the research staff or a HD 
technician or nurse.   
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General Measures 
 Data on demographic features were collected (age, gender, smoker), alongside clinical 
measures (height, post-dialysis weight, interdialytic weight gain (IDWG), presence of diabetes, 
HD vintage in years). Continuous variable measures were taken in triplicate and averaged where 
appropriate.  
Body Fluid and Volume Overload 
 Evaluation of body fluid and fluid overload experienced by a patient was conducted by a 
trained researcher using a portable bioimpedance spectroscopy (BIS) machine (ImpediMed 
SFB7). Patients underwent this non-invasive procedure prior to and following HD treatment 
once during each collection period. For this measure, the BIS system utilized a single channel of 
tetra polar BIS to scan electrical frequencies for patient body composition estimation. Each 
patient was seated and had two electrode leads each placed on their non-access hand and foot on 
the same side of the body. The two hand leads were placed on the wrist next to the ulnar head, 
and on the dorsal surface of the hand. The foot leads were placed on the dorsal surface of the foot 
on the ankle at the level of medial and lateral malleoli, and on the dorsal surface of the foot. This 
low frequency BIS system assessed patient’s extracellular fluid (ECF), intracellular fluid, and 
total body water (TBW). Based on these outputs, the patient’s percent and liters of VO could be 
calculated.22  
Blood Pressure and Medication Use 
BP measures were taken by an HD technician or nurse during every HD session the 
patient attended. For this study, measures of pre-HD BP were recorded during each collection 
period, each on a separate HD treatment day. Prior to the start of HD treatment, patients had their 
BP measured through a sphygmomanometer attached to an HD machine. Patients were asked to 
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sit resting for at least five minutes prior to testing BP on their non-dialysis port arm. Measures of 
systolic and diastolic BP were documented and the treatment commenced. Throughout the 
entirety of the study, patients had their systolic and diastolic pre-HD BP documented six times, 
three pre-intervention and three post- intervention measurements. Following both collection 
periods, systolic and diastolic BP were averaged to interpret the mean pre-intervention BP and 
mean post-intervention BP.  
Patients self-reported how many anti-hypertensive medications they were currently 
prescribed from a physician and taking on a regular basis to help control elevated BP levels and 
HTN. To ensure accuracy, patients brought all current prescriptions to an HD session and 
research staff documented how many were for BP reduction. The number of anti-hypertensive 
medications a patient was prescribed was recorded once during each collection period.  
Nutrition Knowledge 
 Patients were evaluated on their knowledge of nutrition information about protein, 
sodium, and phosphorus prior to and following the intervention period. Questionnaires were 
based on label reading, nutrient content of common foods, and general knowledge related to 
nutrition.23,24,25 Each patient completed this questionnaire one time during each collection period. 
Scores were calculated for percent correctness on each questionnaire.  
Dietary Intake 
 Each patient underwent three 24-hour dietary recalls during each collection period for 
three separate days of food consumption. Recalls were conducted by a trained researcher based 
on the USDA 5-pass method with steps for documenting foods eaten, probing for forgotten foods 
or beverages, prompting for portion sizes, questioning for brand names, and final confirmation of 
the day’s intake (Appendix A). This multi-pass approach collects a patient’s single day dietary 
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intake of food, beverages, vitamins, minerals, and supplements. The three recalls were evaluated 
on a dialysis weekday, non-dialysis weekday, and a non-dialysis weekend day. Each recall 
session lasted approximately 15 minutes. Dietary recalls were conducted verbally and recorded 
by hand then later transferred into the Nutrition Data System for Research (NDSR) software for 
analysis of micronutrient and macronutrient intake. Within the scope of this investigation, a total 
of six 24-hour dietary recalls were completed, three pre-intervention, and three post-intervention. 
After evaluating through NDSR, patient’s dietary intake was consolidated to average pre-
intervention intake and average post-intervention intake and used for analysis.  
Intervention 
Liberalized Renal Diet Education 
Patients were counseled individually on the liberalized renal diet by a researcher twice 
per week for six months. Counseling sessions were held during a patient’s regular HD sessions 
and each lasted approximately 15 minutes. Weekly counseling included individualized 
education, goal setting, and patient support focused on a liberalized renal diet and reducing 
patient sodium intake. Patients discussed their previous week’s meals and adherence to the 
guidelines of a liberalized renal diet (Appendix B). Interviews served to continue discussion and 
education about the diet, and analyze the patient’s progress towards achieving their personal 
goals. Dietary goal setting was conducted through a specific, measurable, attainable, relevant, 
and time-related (SMART) goal model, a validated and reliable method of developing clinically 
based goals26 (Appendix C). 
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Volume Reduction Protocol 
 In combination with reducing an individual’s dietary sodium intake and BP medication 
use, the objective of the volume reduction protocol was to slowly decrease participants’ post-
dialysis weight, thereby decreasing their degree of total VO and ultimately reducing their 
estimated dry weight (EDW). EDW was reduced until either the patient’s BP normalized (below 
140/90 mmHg) or the patient consistently experienced hypotensive events including cramping, 
headaches, or nausea during their HD treatments.  All volume reduction efforts were conducted 
under the supervision of a nephrologist. Nurses and technicians were instructed to decrease the 
post-dialysis weight by 200-300 grams per dialysis session, until pre-dialysis BP measures 
normalized to 140/90 mmHg or less in the absence of antihypertensive medications. HD staff 
were discouraged from administering saline to mitigate complications or discomfort, as were 
patients from requesting saline or a modification of their prescription.  
Statistical Analysis 
 Statistical analyses were conducted using the Statistical Package for Social Sciences 
(SPSS) version 22 (Chicago, IL, USA). Continuous variables were reported as mean and 
standard deviation. Comparison of pre-and post-intervention measurements was conducted using 
the paired t-test. Categorical data was analyzed using the chi-squared test and are reported in 
frequencies and percentages. A p-value <0.05 was accepted as significant for all statistical 
analyses.  
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RESULTS 
Participant Demographics 
Individuals with ESRD receiving maintenance HD at the Peoria, IL and Champaign, IL 
Fresenius dialysis clinics were invited to participate in the study. All 32 patients consented to 
participate, but nine individuals elected to discontinue the study protocol before completion, 
reducing the number of participants to 23. Participants withdrew for various reasons including: 
relocation, transplant surgery, extensive health concerns, and imprisonment. Within the 23 
participants, 12 were males and 11 were females between the ages of 22-81 years old (mean 55.7 
± 13.3 years), of mixed ethnicity (Caucasian, African American, Hispanic) (Table 1).   
Body Fluid and Volume Overload 
Results from BIS allow for comparison of fluid volume and VO changes related to the 
intervention. Significant changes were seen for ECF decreasing from 21.7 (+ 5.8) to 20.5 (+ 4.5) 
L (p=0.004) (Figure 1) and for VO values as well. VO in liters reduced from 3.6 (+ 3.9) to 2.5 (+ 
3.5) L (p=0.01) (Figure 1), a decrease from 15 (+ 15) to 11 (+ 17) % (p=0.04) (Figure 2). TBW 
did not change with intervention (45.8 (+ 10.8) to 44.3 (+ 8.8) L (p=0.10)) (Table 2).  
Weight 
Weight measures for participants were compared following the intervention period, 
including average weight and average IDWG. A significant reduction was seen in patient weight 
on average from 93.6 (+ 24.4) to 91.8 (+ 22.7) kg, (p=0.02), although the drop in average IDWG 
was negligible at 3.2 (+ 1.1) versus 3.0 (+ 1.0) kg, (p = 0.40) (Table 1).  
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Blood Pressure and Medication Use 
Mean pre-dialysis BP measures did not differ for both average systolic and diastolic 
values following the intervention. The non-significant alteration in systolic BP valued at 160 (+ 
25) and 156 (+ 23) mmHg (p=0.56) for pre- and post- measurements, respectively, while 
diastolic BP was 81 (+ 20) and 79 (+ 15) mmHg (p= 0.73). Although pre-dialysis BP 
measurements did not change significantly, anti-hypertensive medication decreased significantly 
after the 6-month intervention period.  On average, anti-hypertensive prescriptions reduced 
significantly from 3 (+ 1) to 2 (+ 1) medications per participant (p=0.003) (Table 3).  
Post Intervention Dietary Intake and Knowledge 
Mean dietary sodium intake, analyzed through 24-hour dietary recalls, decreased non-
significantly following the intervention with measurements of 2,886 (+ 1,570) and 2,315 (+ 
1,095) mg at pre- and post-intervention, respectively (p = 0.125). Additionally, protein 
consumption did not differ before and after the intervention period (61 + 30 before and 56 + 21 g 
protein after, p=0.60). No significant alterations were seen in energy intake per day before and 
after intervention (1,588 +1,061kilocalories (kcals) vs. 1,366 + 455 kcals, (p= 0.38)) (Table 4). 
Nutrition knowledge levels, measured through the percentage correct of questionnaire 
responses, reflect progression following the intervention. Significant improvement was seen for 
average phosphorus knowledge questionnaire scores from 66 (+ 15) to 74 (+14) %, (p= 0.04). 
Although non-significant, progression in sodium and protein knowledge was also seen. Average 
sodium scores increased from 68 (+ 27) to 76 (+30) % (p=0.06) following the intervention, and 
numerical changes in average protein knowledge scores ranged from 81 (+ 18) to 84 (+ 14) %, 
(p=0.25). (Table 5).  
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DISCUSSION 
The main objectives of this study were to explore the impacts of a liberalized renal diet 
with volume reduction on HD patients. Areas of measurement included demographics, dietary 
intake, nutrition knowledge, BP, anti-hypertensive medication use, and body fluid levels. The 
primary new findings of this preliminary intervention study are that individuals receiving a 
liberalized renal diet education alongside volume reduction HD protocol had 1) reductions in 
VO; 2) decreases in average weight; 3) significant reduction in BP medication use with marginal 
differences in BP; 4) improvement in dietary phosphorus knowledge with slight increases in 
dietary sodium and protein comprehension; and 5) minimal variance in dietary sodium, protein, 
and calorie intake.  
Body fluid levels deciphered through BIS were noteworthy on multiple fronts with 
decreases in total VO and ECF. Significant reductions in VO and body fluid retention can likely 
be attributed to the aggressive fluid removal that took place during volume reduction HD 
protocol. By continuously lowering a patient’s target dry weight by 200-300 grams per session, 
their body fluid levels were predicted to gradually decrease. This decrease in body fluid may 
then lead to reduced CV workload, decreased BP, and less edema.21,27 Reduction in a patient’s 
dry weight is beneficial as their dry-weight is often determined only by clinical judgement rather 
than an objective measure of actual patient weight without edema.9 A similar study described 
their fluid removal process as “intensified” and used maximal ultrafiltration (UF) on their 
patients until their BP was below 140/90 mmHg without medication usage,21 with supplemental 
HD session as needed. Similar to our findings, the intensified UF resulted in decreased 
extracellular fluid and blood volume levels, likely benefiting CV health through reduced blood 
volume and stress on the CV system. Coinciding with the overall decreases in body fluid 
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overload, patients also experienced a significant decrease in average weight following the 
intervention. As changes in weight for HD patients are often related to changes in body hydration 
status, this finding is likely correlated with the reduced VO status.9  
A sodium restricted diet is an integral component to success with this modified UF 
protocol as it should decrease patient thirst and overall fluid intake. Ozkahya et al.,21 also 
implemented a sodium restricted diet, and reported significant reductions in BP outcomes with 
little medication usage. Patients in the Ozkahya et al.,21 study had high adherence rates to the low 
sodium diet protocol, which was contrary to the findings within our study. Indeed, other 
investigations reported reductions in sodium intake associated with decreased fluid retention, 
thirst, and BP.6,21,28  
With non-significant reductions in sodium intake, contrary to the hypothesized outcome, 
the reported body fluid reductions are likely unrelated to decreases in sodium intake. Although 
the dietary protocol may not have greatly impacted body fluid levels, the overall decrease in fluid 
overload may in turn reduce patient mortality rates22 and could improve the ability to decipher a 
patient’s actual EDW.29  
As decreases in body fluid overload are related to BP reduction within HD patients9,28, we 
anticipated a resulting decrease in BP for our patients alongside their reduced VO. Contrary to 
expectation, our participants did not have a significant reduction in systolic nor diastolic BP. The 
negligible change seen in BP levels may have been due to poor adherence to the low-sodium 
dietary protocol, as other studies with persistent UF and low sodium diets found success gaining 
control of BP levels following similar interventions.16,21 Due to the minimal sodium restriction 
seen, we hypothesized that our participants did not realize the full extent of possible HTN 
attenuation. With substantial reductions in sodium, our participants could have experienced 
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better VO control, favorable improvement in BP control, and greater preservation of their 
systolic and diastolic functions with little to no reliance on BP medications.7  
Although BP adaptations were not prominent, reduction in overall VO did seem to have a 
positive effect on anti-hypertensive medication uses. On average, our participants significantly 
decreased their medication usage as hypothesized without seeing a consequent rise in BP, 
indicating some improvement in BP control. Though BP levels were stagnant, diminished patient 
dependency on medications may help reduce other concerns such as cardiac stress and mortality 
rates, as well as producing fewer cases of intradialytic hypotension, with decreased severity of 
left ventricular dysfunction.15,16 Our patient’s decrease in body fluid overload likely lowered their 
BP medication needs, while avoiding a subsequent spike in BP. Although there was no 
significant change in BP, it can be hypothesized that with greater low sodium diet adherence, 
patients on a similar UF protocol would experience a decrease in both anti-hypertensive 
medication usage and BP.  
Renal dietitians are the primary providers of nutrition education for HD patients.14 In 
previous interventions, patients received dietary education materials to foster adherence to a 
therapeutic diet.30 In our intervention, we attempted to give customized nutrition education to 
patients through individual counseling sessions. With additional knowledge of nutrition 
concepts, we predicted that individuals in this intervention would adapt their dietary intake based 
on guidelines provided through education modules. Post-intervention, participants displayed 
significantly higher phosphorus knowledge scores, with some improvements in sodium and 
protein knowledge.  
With the nutrition knowledge progress, the outcomes for dietary sodium, protein, and 
calorie intake did not correlate with our prediction. Individuals experienced non-significant 
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decreases in general across these dietary intake categories, yet only sodium reduction was 
specifically targeted in participant counseling sessions. As sodium reduction was a primary 
marker of patient dietary adherence, the non-significant reduction highlights a lack of 
compliance from participants that may have been instigated by barriers for dietary change. 
Difficulty adhering to a reduced sodium diet is not unheard of, as previous investigations have 
indicated multiple barriers HD patients face when limiting sodium intake. Challenges for 
reducing sodium intake include limited availability of low sodium foods, poor intrinsic 
motivation for dietary change, and limited understanding of dietary change and associated health 
outcomes.13,33 
One prominent factor making sodium reduction so difficult is the lack of social support 
patients get from their family and friends.13,31 Patients often feel uncomfortable discussing their 
special dietary needs with their loved ones, and their family is not often involved with education 
sessions, limiting the family’s ability to assist or participate in the dietary changes. Consideration 
for the barriers to understanding and achieving a low sodium diet may be necessary to clarify the 
importance of the diet and encourage inclusion of loved ones in this lifestyle change.  
Additionally, sodium is a component of many food items sold commercially and avoiding 
high salt foods can be almost impossible. Both patients and professionals agreed that avoiding 
sodium in pre-made foods is hard to do and time consuming.13,32 Furthermore, with the increasing 
use of sodium in foods for flavor and preservation32, many individuals have strong taste 
preferences for high sodium foods and they often do not find low sodium foods palatable. 
Although increases in knowledge may be associated with improved therapeutic diet adherence34, 
this may be a weak relationship compared to other contributing factors of dietary compliance.35  
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Neither protein nor kilocalories were recommended for reduction within the liberalized 
renal diet, thus patient’s average numerical decrease in energy and protein intake was 
undesirable. Anorexia is a common barrier seen within the HD population and may have 
prompted the slight decrease in patient consumption.36 The minimal decreases may have also 
been related to the sodium restricted diet approach, as previous research indicates patients may 
decrease total energy intake to minimize sodium intake.11  
Intake documentation utilized 24-hour dietary recalls that require an administrator to 
collect patient self- reported data, which allows low literacy patients to still participate. Dietary 
recall periods following closely after meals also reduces the risk for inaccuracies.37 Nevertheless, 
patient’s self-report of intake presents opportunity for inaccuracy due to over reporting of 
healthy behaviors, under reporting of unhealthy behaviors, changes in behaviors due to the 
research project, inaccuracies based on a participant’s ability to report correct information, or 
other unpredictable errors.38 Alternative methods for monitoring intake exist, but also have 
weaknesses such as generalizing patient food intake and lack of food choices presented in the 
recall.37 Although the 24-hour dietary recall was the best choice for our intervention, the 
unpredictable level of error from patient self-reporting may have skewed the dietary intake 
results. Finally, our participants did spend time with our nutrition research staff during their HD 
treatments, but they did not spend additional time with their clinic’s renal registered dietitian 
(RD). Increasing time spent with their regular renal RD may have produced different dietary 
outcomes.   
Although participants did not achieve all the predicted outcomes, this study design did 
result in various improvements such as a decrease in anti-hypertensive medication use and 
significant reductions in VO. Some of the study’s strengths included a dietary education 
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approach based on individual goals meant to improve specific patient outcomes, and the gradual 
adaptation of an individual’s estimated post dialysis weight through volume reducing UF. Our 
volume reduction process allowed for continuous decreases in each patient’s post dialysis weight 
and re-evaluation of a patient’s EDW, which likely impacted the positive decline in VO.  
Alongside those strengths, areas for improvement and future research opportunities were 
also highlighted including: identifying and targeting personal barriers for dietary success, 
pursuing sustainable and self-motivated dietary goals, seeking to build an individual’s support 
systems for greater dietary adherence, and eliciting greater support for this intervention from HD 
clinic staff.  
The most prominent limitation of this study included a lack of staff participation and 
involvement within the selected HD clinics. Despite attempts to provide information to staff 
regarding the study, the intervention remained an effort conducted by outside research personnel. 
The regular dialysis staff lacked incentive for participation and were already busy. In order for 
this intervention to be truly effective, all HD care providers must be motivated to continually 
display a united message or risk blunted study outcomes. In future interventions, adequate 
training programs and communication techniques should be implemented. Attention to HD staff 
training may improve support and decrease confusion for all dietary and UF protocols and 
encourage all staff to be involved and accountable for patient care.  
Although this study was a positive addition to the body of work surrounding a liberalized 
renal diet and volume reduction protocol, further research is needed in this field to ensure HD 
patients the highest care and quality of life. As many patients experience obstacles keeping them 
from making lifestyle changes, finding greater understanding of each individual’s barriers to 
change may be beneficial for future studies. By identifying and catering a patient’s treatments to 
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their needs, a patient may see increased dietary adherence and improved health outcomes. Future 
interventions may also consider methods of nutrition education outside of the dialysis clinic. 
Presuming internet accessibility, exploring online instruction or video chats may allow for 
inclusion of family and friends in education sessions as well as allowing for alternate locations 
and learning resources. Removing lessons from the dialysis center may encourage greater patient 
comprehension and adherence, while offering the chance to build a patient’s support system, a 
common concern for HD patients.14,33 Further studies should also consider additional lesson 
planning or training modules to educate all dialysis center and research staff on communication 
and appropriate research protocols. By creating open dialogue between the research and dialysis 
center staff, the ultimate goal of providing excellent patient care can better be achieved in 
addition to providing adequate research outcomes.  
CONCLUSION 
Patients experiencing liberalized renal diet education as well as volume reduction HD 
protocol decreased their average anti-hypertensive medication usage, and significantly reduced 
their VO. Although systolic and diastolic BP were unaltered contrary to the hypothesis, the 
stability of BP with a coinciding decrease in anti-hypertensive medication usage supports the 
consideration of lifestyle and UF changes as opposed to pharmaceutical approaches. This study 
provides preliminary evidence for future investigations aimed at lowering HD patient BP through 
sodium reduction and UF changes rather than prescription medication use.   
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CHAPTER II: LITERATURE REVIEW 
INTRODUCTION 
 End Stage Renal Disease (ESRD) has become an increasing public health concern, with 
over 110,000 new cases diagnosed in the United States (US) each year.1 ESRD refers to stage V 
chronic kidney disease (CKD), a disease state in which a patient experiences little to no kidney 
function. One role of healthy kidneys is to filter blood and remove excess fluid and metabolic 
waste from the body, and with inadequate kidney function, that ability is impaired.39 Without 
working kidneys, excess fluid, waste, minerals, and metabolites are poorly excreted through 
urine, influencing accumulation in the body.39 
Metabolite and fluid accumulation leads patients with ESRD to require intensive medical 
care, including dialysis treatments to filter the patient’s blood in absence of adequate kidney 
function.1 Two primary variations of dialysis treatment include peritoneal dialysis, and 
hemodialysis (HD), with HD being the most frequently selected treatment.39,40 In the US, HD is 
typically a four-hour treatment that patients receive in a specialized facility, three times weekly.39 
HD serves to remove the excess substances built up in the patient’s body that would have 
otherwise been excreted as urine under normal circumstances.39 During the time between dialysis 
sessions, also known as the interdialytic period, excess minerals and organic metabolites 
accumulate in the body, which can cause disturbances in the body’s fluid status. Within HD 
patients, expansion of blood volume, and large interdialytic fluctuations of total fluid volume 
between HD treatments can increase or exacerbate health risks including cardiovascular diseases 
(CVD) such as hypertension (HTN).7 With upwards of 80-90% of HD patients experiencing 
HTN8, and CVD being the main cause of death among ESRD patients encompassing 41% of 
patient deaths10, prevention and treatment strategies are needed to overcome the HTN and CVD 
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risks HD patients face. Common approaches to alleviate the negative health impacts of HTN in 
the HD population include various lifestyle changes and pharmaceutical approaches.  
LITERATURE REVIEW 
 
The Traditional Renal Diet 
High mortality rates secondary to CVD within the HD population are concerning and 
dietary approaches are often recommended for HTN and CVD risk control. Interdialytic blood 
metabolite accumulation is a hallmark of the disease, upsetting fluid balance in the body. 
Traditionally, renal diet recommendations promote dietary mineral restrictions in hopes of 
preventing irregular blood mineral concentrations and fluid shifts. These traditional renal diet 
guidelines are quite restrictive, with limitations focused on sodium, potassium, and phosphorus 
intake for HD patients.3  
Dietary Sodium 
 In terms of HTN and CVD, a primary nutrient of concern is sodium. Sodium is a mineral 
and electrolyte important for fluid regulation and blood pressure (BP). Sodium is the principle 
extracellular cation, and is a strong moderator of water absorption and retention, with high 
sodium levels correlated to water retention.41 For HD patients unable to excrete excess fluid 
waste appropriately, any consumed sodium and in turn retained water will increase blood 
volume.41 This increase in blood volume then elevates BP, leading to development or 
exacerbation of HTN. In addition to sodium’s strong ability to retain water, it also plays a role in 
thirst. Thirst for fluids is a physiological stimulus that can be increased if the body contains 
excess sodium levels.6 This stimulus is so strong, asking an individual to limit their fluid intake 
without instructing them on sodium limitations has even been considered inhumane.6 Because 
HD patients are limited in their fluid waste excretion, any additional fluid intake will impact their 
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blood volume, and can lead to cardiovascular (CV) concerns including HTN and aortic stiffness7, 
supporting the need to restrain thirst. Because sodium causes the body to retain water, and 
increases an individual’s thirst and drive to consume liquids, high sodium intake can drastically 
alter blood volume and pressure.41 In an investigation with greater than 30,000 individual HD 
patients, large gains of body fluid between dialysis sessions, more than 4.0 kg, were correlated 
with higher risk of death over the two years following9, indicating the need for interventions. 
HTN rates are so elevated, effecting an estimated 80-90% of HD patients8, and CVD risk is 
rampant for HD patients. As blood volume overload (VO) is predicted as one of the most 
frequent components of HTN progression27, there is a strong argument for sodium restriction 
within this population.  
Based on this concept, adjusting sodium intake has been investigated as a treatment for 
fluid retention and HTN within the HD population. A study by Maduell and Navarro17, attempted 
to reduce dietary sodium intake in HD patients. Decreasing sodium intake led to significant 
reductions in patient’s systolic and diastolic BP. From this 15-subject study, researchers found 
sodium limitations to be an important controller of HTN in HD patients, and found sodium 
restrictions to be more effective than antihypertensive medications for lowering BP.17  
Although sodium restrictions could be a strong determinant of fluid balance and HTN in 
HD patients, there are challenges to decreasing sodium intake. Sodium is used as a preservative 
for many processed food products and is highly abundant in restaurant foods as well.32As most 
foods are naturally low in sodium, foods that have been modified or processed prior to 
consumption are the most common source of sodium in the American diet. With an abundance of 
sodium available for US consumers, most Americans meet and exceed daily recommended 
sodium intake for adults.32 Increased access and intake of sodium rich foods creates concern in 
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regards to elevated body fluid levels, and CVD risk for HD patients is greatly increased with 
excess sodium intake. Elevated body fluid poses a serious CV threat to HD patients, and due to 
sodium’s strong correlation with overall fluid retention, considerations should be make regarding 
sodium intake for HD patients.  
Dietary Potassium 
 Another nutrient of concern that can accumulate in the blood between HD sessions is 
potassium. Traditional renal diet recommendations include guidelines for potassium intake to 
discourage accretion of potassium in the blood.39 Hyperkalemia, excess blood potassium, is the 
most common metabolite abnormality for HD patients.42 Hyperkalemia is associated with higher 
risk of CV mortality for HD patients43, making alterations in dietary potassium and other medical 
treatments a focus for HD patients to achieve optimal blood potassium levels.  
Dietary potassium limitations are traditionally recommended for HD patients to support 
potassium balance and decrease hyperkalemia risk. However, strict potassium limits can pose 
concerns for various food groups due to the high potassium concentration in many nutrient rich 
foods. Some foods that are naturally high in potassium include fruits, vegetables, nuts, and 
legumes, foods that are also notably high in fiber and beneficial nutrients.44 Potassium is also 
used as an additive to many products including soft drinks and bread, illustrating how difficult 
avoiding dietary potassium can be.45 Decreasing hyperkalemia risk is still essential to reducing 
CVD risk, but restriction of all potassium foods may not be necessary. Data linking naturally 
potassium rich foods to adverse health outcomes is limited.43 Furthermore, foods with potassium 
added for preservative or flavor purposes often have low nutrient density and are not typically 
favorable selections.20 With limited research discussing the benefits and downsides of natural 
potassium in nutrient rich foods, these recommended limits may be unnecessarily strict. 
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Additionally, as foods with added potassium are often nutrient poor, these foods should likely be 
the initial target when removing potassium containing foods from the diet. Continuing research is 
pursuing investigation of what quantity of natural and added potassium is safe for HD patients.20 
Although a patient may require potassium intake limitations, restricted consumption of foods 
naturally containing potassium may be less necessary than previously indicated.20 With limited 
data supporting dietary potassium restrictions, fresh produce and other natural potassium 
containing foods may still be safe for HD patients. Further evidence is needed to determine 
appropriate potassium recommendations for HD patients.   
Dietary Phosphorus 
 Phosphorus, similar to potassium, is another mineral causing concern for HD patients 
with the potential of hyperphosphatemia, or high blood phosphorus46, due to patient’s limited 
excretion of phosphorus through urine. Limitations on all dietary phosphorus are traditionally 
noted as a preventative method for HD patients to avoid hyperphosphatemia, but recently, this 
ideology is being challenged.47  
 Foods that are naturally high in phosphorus include milk, cheese, beans, and meat42, with 
other foods such as carbonated sodas and processed foods being high in phosphorus from 
additives and preservatives.32 Research indicates that inorganic phosphorus added to foods 
during processing has up to 100% absorption rates within the gut, in comparison to the 40-60% 
of natural phosphorus that is absorbed from unprocessed foods.47 Although absorption rates 
differ, dietary recommendations do not decipher between naturally phosphorus rich foods and 
those with added phosphorus from processing.47 Furthermore, natural phosphorus is often present 
in foods with higher levels of protein and/or fiber, indicating extensive dietary phosphorus 
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limitations may be harmful to an individual’s ability to consume adequate protein47, a consistent 
concern for this population.36  
 In efforts to avoid hyperphosphatemia, while maintaining adequate protein and energy 
intake, avoidance of phosphorus additives and processed foods is indicated, without limitation on 
natural phosphorus and protein rich foods.47 This method will allow patients greater food variety 
and could improve patient protein intake, common HD patient concerns.14 Additionally, patients 
may have improved health outcomes as more restrictive phosphorus recommendations have been 
associated with higher mortality rates among HD patients.46 With research indicating differences 
between added and naturally occurring phosphorus, patients may be able to avoid 
hyperphosphatemia by eating foods such as meats, beans, and dairy, while actively avoiding 
added phosphorus within processed foods.  
Traditional Renal Diet Challenges 
The traditional renal diet has been described as one of the most challenging diets a 
dietitian can prescribe to patients11, including limitations on sodium, potassium, and phosphorus. 
Unfortunately, this restrictive diet produces limited health outcomes in terms of HTN and CVD. 
Previous studies have investigated guidelines for limiting mineral consumption for HD patients, 
often noting foods such as beans, root vegetables, and fruits as high in unhealthy minerals.44 In 
addition to the general challenge of attempting to understand and achieve these strict dietary 
goals, further barriers are seen in terms of processed foods. Many patients are not educated on 
levels of minerals present in highly processed food items, with process foods being defined as 
those items that have been deliberately changed in some way from the time of origin to the time 
of consumption.48 Processed foods may not be on the exclusion list traditionally given to HD 
patients, but these foods likely contain unhealthy amounts of minerals.32 Additionally, processed 
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foods are more often insufficient in fiber and essential nutrients, components HD patients 
traditionally lack within their diet, while still containing astonishingly high amounts of sodium.12 
Traditional renal diet guidelines are currently limiting patient food options, while being unclear 
about the use of processed foods and the sodium content that may be hiding within these 
products.32,49 With the expansive presence of processed foods and mineral additives used for 
flavor and preservation, identifying and avoiding foods high in sodium, potassium, and 
phosphorus can be difficult.32,44 
With traditional renal dietary limitations in place, HD patients are also particularly prone 
to suffering from protein-energy wasting11, including multiple nutritional and catabolic 
alterations that occur alongside kidney disease and failure.36 By reevaluating these past 
guidelines, a patient may be able to improve their nutrition status with liberation of phosphorus 
intake and inclusion of the previously limited dairy and meat food groups.47 Moreover, guideline 
reconsideration may improve the vitamin and mineral deficiencies HD patients typically 
display11,50 with more freedom regarding fruit and vegetable intake, previously limited due to 
high potassium concentration.14,44 With indication that naturally-occurring potassium and 
phosphorus rich foods may be safe for patients to consume, some guidelines of the traditional 
renal diet may be less necessary than previously thought.  
Additionally, the complex guidelines of the traditional renal diet may detract attention 
from the sodium limitations patients likely need to focus on to improve their HTN and CV risk. 
Extensive dietary guidelines can incur poor dietary adherence based on a patient’s ability and 
desire to pursue behavior changes. This includes patient differentiation in terms of cognitive 
abilities, cultural norms, and perception of potential health outcomes.51 When delving further into 
this issue, difficulties with social support, inadequate guidance offered to the patient by a health 
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care provider, and limited patient understanding of disease state increasingly limits dietary 
adherence.13,14 As these guidelines are extensively complicated, some patients are unable to 
comprehend the information necessary for success. Also, patients who are unable or unwilling to 
adhere to dietary recommendations will not achieve highly on this restricted diet.13,14 HTN and 
excessive fluid retention are discussed in many research articles and the use of dietary sodium 
restriction is often noted.5,15,17 These articles strongly advocate for limitations in dietary sodium, 
but provide little information as to how the process of moving towards a low sodium diet may 
work. Additionally, they lack documentation as to the potential change in BP and anti-
hypertensive medications that may ensue should an individual limit their sodium intake. Though 
potentially applicable to American HD patients, most related research is conducted outside of the 
US. There is a possibility for the positive sodium restricted diet outcomes seen in Italy, Turkey, 
and France7,15,16 to also take place within the US, but further research is needed to confirm. 
Research is also needed to investigate the process of limiting sodium and the related outcomes, 
which will be relevant in future research for patients and practitioners to understand sodium 
restriction benefits for HD patients. 
The challenges identified with the traditional renal diet make it difficult to pursue, and 
the identified weakness of its recommendations truly contest the necessity of this diet. In efforts 
to create a diet that patients can understand and achieve when they are ready for behavioral 
modifications, further investigation is warranted to determine meaningful and attainable dietary 
recommendations for HD patients.  
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Anti-Hypertensive Medications 
As discussed previously, BP control is crucial for HD patients to maintain their CV 
health due to their limited liquid waste excretion and blood metabolite build up. In addition to 
diet or lifestyle changes, pharmaceutical treatment approaches are an option to achieve 
recommended BP levels.  
Anti-hypertensive medications are identified as the most common method of treatment 
for HD patients with HTN5, with multiple types of anti-hypertensive medications being 
prescribed individually or in tandem.27 With many classes of medications available, patients can 
receive multiple prescriptions with varying outcomes depending on their CV health, 
comorbidities, and physician. In general, the US is one of the highest users of anti-hypertensive 
agents.52 Poly-pharmaceutical therapies are so common, that amongst a group of 205 American 
HD patients taking antihypertensive medications, 58% of those individuals were taking two or 
more medications daily.18  
With a poly-pharmaceutical approach in place, improved BP outcomes would be 
expected, but medication based therapies often have limited effects on BP. In a study of 2535 
HD patients prescribed one or more anti-hypertensive medications, 55-75% of patients remained 
hypertensive above 140 mmHg for their systolic BP.27 Limited outcomes for BP management 
may be related to the varying etiologies of HTN, as patients with HTN unrelated to blood VO 
seem to fair better to the treatment, as opposed to those individuals who have excessive blood 
volume impacting their BP.27 As many HD patients have VO contributing to their HTN, the 
likelihood of success with anti-hypertensive medications is limited. It is likely that a treatment 
reducing total blood VO will have greater impact on HD patient BP than altering other targets.27 
In addition to inadequate BP reduction outcomes, pharmaceutical approaches have challenges 
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including cost, side effects, and initiation and maintenance of medication routines. For patients, 
unfamiliar or unable to access affordable medication options, adherence and maintenance to the 
medication regimen may be difficult. Furthermore, some patients challenged with handling their 
own care including continuous medication usage can increase concern for misuse or poor 
medication adherence due to limited ability to care for themselves and maintain medications.5,15,18 
Although medications are a commonly prescribed approach for HTN reduction, the outcomes are 
limited and use is challenging for numerous HD patients, indicating need for further HTN 
treatment consideration.  
Ultrafiltration Techniques  
 The process of HD is an ultrafiltration (UF) of a patient’s blood to remove excess waste 
and fluids retained between dialysis sessions. Traditional US HD processes are successful in 
removing some excess fluid and metabolites from the blood based on a patient’s estimated dry 
weight (EDW). The EDW is predicted at each dialysis session by a nephrologist, and is based on 
the practitioner’s best approximation of a patient’s weight if they did not have any excess fluid 
retention.9,21 Although these estimations can be close, the ability for the practitioner to accurately 
predict every patient’s EDW, every session, is unlikely. Even with substantial levels of human 
error, limited options for predictive methods have led to EDW being the standard approach for 
nephrologists writing UF prescriptions.9 Although traditional HD approaches for American 
patients use EDW quite consistently39, some researchers have discussed altering UF approaches 
to improve BP and VO outcomes. Many of the most successful approaches to decreasing HTN in 
HD patients includes using extended or more frequent HD sessions, allowing for greater fluid 
removal and blood volume management.27Another investigation looked at providing four-hour 
HD sessions removing as much fluid as the patient could safely tolerate, with additional HD 
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sessions as indicated for elevated blood volume and BP.21 This approach did not utilize EDW to 
determine the UF prescription, but instead used UF to consistently decrease BP without causing 
severe instances of hypotension or other contraindications to fluid removal.21 Through this 
technique more fluid was removed allowing patients to come closer to a status of little to no fluid 
retention. With this personalized approach to the UF protocol, patients in this study saw 
decreases in cardiac volume, and BP control was more easily achieved, leading researchers to 
expect improved CV outcomes.21 Further reinforcement for individualized approaches to HD 
treatments are recommended due to the fine precision available through HD technology currently 
used at HD clinics. With the ability to create unique HD prescriptions based on a patient’s 
individual needs at the time of their session, opportunities for improving BP and fluid balance 
are available.53 Unfortunately, many HD clinics note difficulties regarding cost and staff training 
levels as reasons to not pursue unique and adaptive HD prescriptions.53 With variations of UF 
treatments indicating potential improvements for BP and CVD risk, HD patients with HTN may 
be good candidates for alterations in the UF prescription as achievable to provide improved 
health outcomes.  
Comparing Hypertension Management Techniques  
 Due to the high prevalence of HTN and CVD in HD patients, determining appropriate 
treatment approaches is vital to patient health outcomes. With distinct differences between 
dietary changes, pharmaceutical approaches, and UF techniques, pinpointing the best treatment 
plan can be puzzling. Some HD clinics are making transitions in their daily patient care in efforts 
to reduce BP.  
Conversion from a medication based therapy for HTN to sodium restriction and UF 
therapy has taken place overseas in countries such as France. In a comparison of two respected 
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European HD centers, a French clinic had distinguished differences in survival rates and BP.15 
Investigating the mortality among patients at these clinics, the survival rate is markedly higher at 
the French HD center, hypothesized to be related to the low prevalence of HTN among the 
patients. The French clinic functions on a reduced sodium diet approach for BP regulation 
accompanied by extended eight hour HD sessions to decrease blood VO. The English clinic 
recommends a medication based approach for HTN with traditional four hour HD treatments, 
similar to that of the US. With superior life expectancy outcomes for the French patients 
provided low sodium diet recommendations and altered HD treatments, this research may call for 
reevaluation of a medication based approach. In this case, sodium restriction and UF changes in 
the French clinic seemed to decrease HTN as well as mortality rate, whereas anti-hypertensive 
medications seemed to make less impactful differences, if any at all.15 For comparison to the US, 
total sodium intake for the patients at the French clinic was about 1700 milligrams per day15, 
with American patients consuming an average of 4200 milligrams of sodium daily54, indicating 
opportunity for sodium intake improvements. This study’s findings are not alone, as similar 
outcomes are seen in Turkish HD centers.  
  In a comparison between Turkish and American dialysis patients, individuals were 
evaluated for HTN as well as mortality rates. For hypertensive US HD patients, medications are 
often the primary treatment, alongside recommendations for the traditional renal diet. However, 
Turkish patients follow approaches to reduce over hydration with more aggressive fluid removal 
during HD, as well as a strict dietary sodium restriction without the potassium and phosphorus 
limitations of the traditional renal diet. The combination of aggressive fluid removal during 
dialysis and focusing dietary recommendations solely on sodium intake appears to improve BP 
in most Turkish patients. With a 50% lower mortality rate among Turkish patients, it is likely 
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that Turkish approaches to blood VO and sodium limitations are more effective than those used 
in the US.55 
One of the few comparison studies, Kayikciogly et al.16, tracked hypertensive HD patients at 
two separate dialysis clinics treated with either a low sodium diet or anti-hypertensive 
medications and compared BP outcomes. The 423 HD patients involved in this Turkish study all 
received the same HD treatment approach. Individuals at Center A were actively recommended a 
2000 milligram sodium diet daily for HTN, rather than being passively recommended a reduced 
sodium diet and relying on anti-hypertensive medications provided at Center B. At Center A, 
dietary sodium restriction indicated less strain on patient’s left heart ventricle indicating better 
function, lower risk of hypotension following HD treatments, and improved systolic and diastolic 
function. Additionally, patients adhering to a sodium restricted diet experienced lower 
interdialytic weight gain (IDWG) between dialysis sessions than those only taking anti-
hypertensive medication16, and notably lower IDWG is associated with greater survival rates.9 
Following the conclusion of this trial, the positive CV outcomes indicate the therapy from Center 
A, using sodium restriction, was more beneficial.9 
Further investigations to decrease total blood volume and fluid retention with sodium 
limitations had similar findings. Within a study of 15 HD patients, a dietary sodium limitation 
was an important controller of HTN. These individuals experienced decreases in both systolic 
and diastolic BP through the dietary sodium restriction, and the dietary lifestyle approach was 
considered more effective than medication use, though no medications were compared within 
this study.17 An additional case discussing sodium restriction and BP regulation for HD patients, 
used an intervention approach to decrease dietary sodium intake from an average of 4.1 grams of 
sodium per day to 2.8 grams of sodium per day. This intervention aided in significantly reducing 
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patient systolic BP54, further supporting this platform. This strong viewpoint contradicts the 
current popularity of anti-hypertensive drugs for HD patients.5 But although the transition from 
medication based treatments to dietary approaches may seem beneficial, barriers to transitioning 
from a pharmaceutical approach to a low sodium diet are still impacting patient success.  
Dietary Sodium Reduction Challenges 
Regardless of the strong research supporting use of a low sodium diet for BP control in 
HD patients, there are continued personal and cultural barriers to this lifestyle. Studies often note 
the challenges of following a sodium restricted diet including; inadequate access to low sodium 
foods, lack of self-motivation or family support, varying dietary beliefs, personal attitudes, and 
poor taste acceptance.13,31 With patients experiencing universal barriers to lifestyle changes as 
well as those unique to them as an individual, finding approaches to overcoming these obstacles 
is vital to patient success. Recent literature has considered ways to improve patient adherence, 
with a large focus on increasing accessibility to lower sodium foods for patients following this 
diet.  
Sodium is often used in food processing as a preservative or to improve food taste.32 
Foods naturally contain relatively low amounts of sodium, but approximately 75% of American 
sodium intake comes from sodium added during processing.32 In efforts to control sodium 
additions in processed foods, one study experimented with minimizing the sodium content of 
common foods.56 Researchers decreased sodium additions by an estimated 50% in almost all 
food categories and indicated that this would result in a 38% decrease of daily dietary sodium 
intake for most individuals.56 Similarly, guidelines for maximum values of sodium additions are 
being considered in efforts to decrease sodium consumption in America.49 These guidelines 
would limit processing companies’ ability to exceed the maximum sodium amount designated, 
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and may decrease individual’s daily sodium intake.49 It appears there is a great possibility to 
change within the food industry that may benefit the sodium restrictions needed by HD patients.  
Some concerns that may arise from the low sodium diet approach have been noted by 
researchers, including risk of undernutrition. Some studies indicate that individuals may not 
receive adequate amounts of micro and macro nutrients while on a limited sodium diet.11 
Although it can be challenging to find some low sodium food alternatives, it appears that patients 
can adequately achieve energy and protein intake with appropriate alternative food selections.11,57 
Additionally, considering the other option of the restrictive traditional renal diet, the low sodium 
diet approach will likely provide more nutrients than the alternative. Further success on the low 
sodium diet can be found with maintenance of protein intake, as that indicates increased survival 
rates.11 With consideration for nutrients at risk while on a sodium restricted diet, patients can 
improve their HTN by consuming an adequate diet, specifically rich in protein and fulfilling 
energy needs.  
By using low sodium and minimally processed products, an individual can successfully 
lower their sodium intake, which can decrease BP, while still maintaining health. This sodium 
limitation approach is not always easy to follow, but may be a more successful alternative 
therapy to anti-hypertensive medications.   
Reconsidering HTN Treatment in the US 
 Research regarding sodium restriction for decreasing HTN among HD patients is not 
unheard of, but it appears the US is struggling to include that concept into practice. Medications 
are the most common treatment for HTN within the US. Unfortunately, with medication usage, 
the effects on BP within this population seem to be limited, with less than half of patients able to 
regaining control of their BP.58 Not only is this approach minimally effective for patients, but it 
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may dissuade the introduction of a dietary approach that could have more effective outcomes. If 
US HD clinics start to approach HTN treatments with a dietary sodium limitation, patients may 
be able to experience outcomes similar to those in France and Turkey, with lower BP as well as 
decreased left ventricular stress and reduced patient mortality rates.15,16,54,55 Additional 
opportunity for improvements may be seeded within the UF protocol and prescriptions provided 
to HD patients, allowing for greater individualization opportunities.9,21,58  
 Recent research developments challenge the details of the traditional renal diet, as well as 
support dietary sodium changes versus medication based HTN management. Based on current 
research, reconsideration of these guidelines should focus on diet achievability and patient needs, 
while being conscious of minerals and providing adequate nutrients.11,20 These proposed dietary 
recommendations would include limiting foods high in sodium additives such as processed or 
restaurant foods. Additionally, this diet would allow more freedom for foods that are naturally 
rich in potassium and phosphorus. By focusing a patient’s energy on reducing sodium instead of 
the traditional renal diet, a patient will have greater food selections and may increase their ability 
to find success achieving dietary changes. With the reconsideration of the traditional renal diet 
and stronger focus on dietary sodium reduction, patients may experience positive CV health 
outcomes, and decreases in systolic and diastolic BP, potentially even enough to warrant reduced 
anti-hypertensive medication use. Utilization of this low sodium focus may be further improved 
through individualized UF protocol, focused on improving a patient’s VO and BP status, rather 
than on EDW. As investigations are limited regarding this low sodium diet focus and unique UF 
prescriptions within the US, further research should be considered to allow HD patients 
opportunities to achieve the beneficial health outcomes seen through low sodium diet and 
individual UF approaches in other countries.   
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Table 1. Baseline Patient Characteristics 
Demographics and Clinical Data Participants (n=23) 
Age in years (standard deviation) 55.7 (13.3) 
Male (%) 12(52.2) 
Hispanic (%) 1(4.5) 
African American (%) 9 (40.9) 
Patients w/ Diabetes (%) 10 (45.5) 
Avg. Weight in kg (standard deviation) 93.6 (±24.4) 
Avg. IDWG in kg (standard deviation)  3.15 (±1.1) 
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Table 2. Body Fluid Levels 
Bioimpedance 
Spectroscopy Data 
Pre-Intervention Post-Intervention p-value 
Total Body Water in Liters 45.8 (±10.8) 44.3 (±8.8) 0.10 
Total Body Water % 49.8 (±7.1) 49.4 (±6.4) 0.61 
All values presented are mean (standard deviation). n=23 
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Table 3. Blood Pressure and Medication Outcomes 
Blood Pressure Data Pre-Intervention Post-Intervention p-value 
Systolic BP in mmHg 160 (±25) 156 (±23) 0.56 
Diastolic BP in mmHg 81 (±20) 79 (±15) 0.73 
# BP Medications 3 (±1) 2 (±1) 0.003 
All values presented are mean (standard deviation). n=23  
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Table 4. Dietary Intake Evaluation 
Dietary Intake Data Pre-Intervention Post-Intervention p-value 
Energy Intake in kcals 1588 (±1061) 1366 (±455) 0.38 
Protein Intake in grams 61 (±30) 56 (±21) 0.60 
Protein Intake in g/kcal 0.72 (±0.50) 0.65 (±0.28) 0.79 
Sodium Intake in mg 2886 (±1570) 2315 (±1095) 0.13 
Sodium Intake in mg/kcal 1.96 (±0.84) 1.69 (±0.53) 0.16 
All values presented are mean (standard deviation). n=23 
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Table 5. Dietary Knowledge Evaluation 
Dietary Knowledge Pre-Intervention Post-Intervention p-value 
Protein Knowledge % Correct  81 (±18) 84 (±14) 0.25 
Phosphorus Knowledge % Correct  66 (±15) 74 (±14) 0.04 
Sodium Knowledge % Correct  68 (±27) 76 (±30) 0.06 
All values presented are mean (standard deviation). n=23 
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Figure 1. Reduction in Liters of Volume Overload Following Intervention. 
 
 
 
 
 
 
 
 
 
 
 
 
All values presented are mean (+ standard deviation) 
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Figure 2. Significant Post-Intervention Improvement in Volume Overload Percentage. 
 
 
 
 
 
 
 
 
 
 
 
All values presented are mean (+ standard deviation) 
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APPENDIX A: 24-HOUR RECALL FORM 
Pt ID: __________     Researcher: __________  
 
Date Consumed: _________________  Date Recorded: _________________ 
 
Meal Time Food/Drink Portion/Brand Location 
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APPENDIX B: PATIENT SUMMARY SHEET 
 
           Pt ID: _____ 
Goal Setting: 
Initial Date Goal (SMART) Aim Achievement Date 
 
 
Date: ____/____/_______ 
  
 
Date: ____/____/_______ 
 
 
Date: ____/____/_______ 
  
 
Date: ____/____/_______ 
 
 
Date: ____/____/_______ 
  
 
Date: ____/____/_______ 
 
 
Date: ____/____/_______ 
  
 
Date: ____/____/_______ 
 
Current Habits: 
Positive Habit Strategies for Maintaining Habit 
  
  
  
Concerning Habit Strategies for Improving Habit 
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APPENDIX C: GOALS TEMPLATE 
Pt ID: ___________   Current Date: ___________ Researcher: ______________ 
 
Current Goal #1 
Initial Set Date: ____/____/________ Actual Achievement Date:  ____/____/________ 
Goal:  
 
 
 
 
Aim Achievement Date: 
____/____/________ 
Are all SMART components met? (yes/no) - Specific: ______________________ - Measurable: __________________ - Attainable: ______________ - Relevant: ______________________ - Time Related: _______________ 
 
Did the patient achieve this goal? How did they achieve it, or why did they not achieve it? 
____________________________________________________________________________
____________________________________________________________________________
__________________________________________ 
If the goal was not achieved, restructure the goal to the SMART model and patient 
needs: - Was it specific enough to achieve?  - Can you specify the measurement to be numerical/unit based rather than more/less? - Can this patient achieve this action within the specific time period? - Is there a clear time frame?  - Utilize the goal builder section to improve this goal for better achievement 
If the goal was achieved: - Use the goal builder section to develop this goal even further for the patient - Use the goal builder section to create a new goal in an area that has not yet been 
approached by this patient  - Use successful approaches of the last goal to fuel the new goal 
 
Goal Builder #1: 
Current Date: ____/____/________ Aim Achievement Date: ____/____/________ 
Goal:  Are all SMART components met? (yes/no) - Specific: ______________________ - Measurable: __________________ - Attainable: ______________ - Relevant: ______________________ - Time Related: ________________ 
Additional notes or sub-goals for success: 
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
________________________________________ 
 
